Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of ularitide in acute decompensated heart failure
2005-003800-12Phase 2Completed
- Sponsor
- PDL BioPharma
- Start
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Ularitide with Placebo (2 arms). Primary endpoint: Composite clinical response responder rate at 24 and 48 hours. Started Feb 2006; status: completed.
02
Drugs
ularitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2005-003800-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003800-12.